TGF- regulates the proliferation of lung adenocarcinoma cells by inhibiting PIK3R3 expression

被引:12
作者
Wang, Guihua [1 ]
Yang, Xi [1 ]
Jin, Yuan [1 ]
Deng, Yu [2 ]
Luo, Xuelai [1 ]
Hu, Junbo [1 ]
Wang, Jing [3 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Canc Res Inst, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Thorac Surg, Wuhan 430030, Peoples R China
[3] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Immunol, Tongji Med Coll, Wuhan 430030, Peoples R China
关键词
TGF-beta; cell proliferation; PIK3R3; lung adenocarcinoma; GROWTH-FACTOR-BETA; CANCER-CELL; TRANSFORMING GROWTH-FACTOR-BETA-1; PI3K; SUBUNIT; TRANSCRIPTION; CHALLENGES; NKX2.1; SMADS;
D O I
10.1002/mc.22243
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PIK3R3, an isoform of class IA phosphoinositide 3-kinase (PI3K), specifically interacts with cell proliferation regulators, such as retinoblastoma and proliferation cell nuclear antigen, to promote cell proliferation. However, the mechanisms behind the upstream signaling pathway of PIK3R3 remain unclear to date. This study showed that PIK3R3 expression was regulated by transforming growth factor- (TGF-) signaling and that PIK3R3 mediated the TGF--induced inhibition of lung adenocarcinoma cell proliferation. TGF- down-regulated PIK3R3 expression in lung adenocarcinoma cells. However, this TGF--induced inhibition of cell proliferation can be attenuated by PIK3R3 overexpression. In addition, TGF- can attenuate the transcriptional activity of NKX2.1, a transcription factor that binds to the promoter of PIK3R3. This result indicated that TGF- regulated PIK3R3 expression by targeting NKX2.1. We confirmed the correlation between NKX2.1 and PIK3R3 in clinical samples. Therefore, the TGF-/NKX2.1/PIK3R3 axis is crucial in the TGF--induced inhibition of cell proliferation, and the NKX2.1/PIK3R3 axis might become a target in TGF- receptor-repressed lung adenocarcinoma. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:E162 / E171
页数:10
相关论文
共 34 条
  • [1] Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
    Burdett, Sarah
    Rydzewska, Larysa H. M.
    Tierney, Jayne F.
    Auperin, Anne
    Le Pechoux, Cecile
    Le Chevalier, Thierry
    Pignon, Jean-Pierre
    [J]. LANCET, 2014, 383 (9928) : 1561 - 1571
  • [2] TGF-β1 and FGF2 Stimulate the Epithelial-Mesenchymal Transition of HERS Cells Through a MEK-Dependent Mechanism
    Chen, Jie
    Chen, Guoqing
    Yan, Zhiling
    Guo, Yongwen
    Yu, Mei
    Feng, Lian
    Jiang, Zongting
    Guo, Weihua
    Tian, Weidong
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (11) : 1647 - 1659
  • [3] The PI3K Pathway As Drug Target in Human Cancer
    Courtney, Kevin D.
    Corcoran, Ryan B.
    Engelman, Jeffrey A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 1075 - 1083
  • [4] Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis
    Forrester, E
    Chytil, A
    Bierie, B
    Aakre, M
    Gorska, AE
    Sharif-Afshar, AR
    Muller, WJ
    Moses, HL
    [J]. CANCER RESEARCH, 2005, 65 (06) : 2296 - 2302
  • [5] PI3K and cancer: lessons, challenges and opportunities
    Fruman, David A.
    Rommel, Christian
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (02) : 140 - 156
  • [6] TGF-β signaling to chromatin: How Smads regulate transcription during self-renewal and differentiation
    Gaarenstroom, Tessa
    Hill, Caroline S.
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 32 : 107 - 118
  • [7] Transforming growth factor-β and breast cancer risk in women with mammary epithelial hyperplasia
    Gobbi, H
    Dupont, WD
    Simpson, JF
    Plummer, WD
    Schuyler, PA
    Olson, SJ
    Arteaga, CL
    Page, DL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (24) : 2096 - 2101
  • [8] ALK inhibitors in the treatment of advanced NSCLC
    Gridelli, Cesare
    Peters, Solange
    Sgambato, Assunta
    Casaluce, Francesca
    Adjei, Alex A.
    Ciardiello, Fortunato
    [J]. CANCER TREATMENT REVIEWS, 2014, 40 (02) : 300 - 306
  • [9] A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy
    Hu, Junbo
    Xia, Xianmin
    Cheng, Aiwu
    Wang, Guihua
    Luo, Xuelai
    Reed, Michael F.
    Fojo, Tito
    Oetting, Alexis
    Gong, Jianping
    Yen, Paul M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (12) : 3719 - 3728
  • [10] Recent Clinical Advances in Lung Cancer Management
    Johnson, David H.
    Schiller, Joan H.
    Bunn, Paul A., Jr.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (10) : 973 - 982